EMC Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Buy
+6,696
New +$5.55K ﹤0.01% 52
2025
Q4
$44K Hold
6,446
0.02% 256
2025
Q3
$48K Buy
6,446
+25
+0.4% +$212 0.02% 266
2025
Q2
$49K Buy
6,421
+25
+0.4% +$389 0.03% 253
2025
Q1
$83K Buy
6,396
+4,169
+187% +$131K 0.05% 236
2024
Q4
$81K Buy
2,227
+1,307
+142% +$36.4K 0.05% 236
2024
Q3
$638K Sell
920
-5,276
-85% -$117K 0.42% 24
2024
Q2
$140K Hold
6,196
0.08% 207
2024
Q1
$411K Hold
6,196
0.25% 56
2023
Q4
$638K Hold
6,196
0.43% 20
2023
Q3
$613K Buy
6,196
+5,752
+1,295% +$536K 0.45% 18
2023
Q2
$83 Sell
444
-5,752
-93% -$729K 0.06% 233
2023
Q1
$517K Hold
6,196
0.43% 17
2022
Q4
$527K Buy
6,196
+3,442
+125% +$263K 0.47% 15
2022
Q3
$275K Hold
2,754
0.25% 52
2022
Q2
$62K Hold
2,754
0.05% 260
2022
Q1
$135K Hold
2,754
0.1% 187
2021
Q4
$159K Sell
2,754
-1,038
-27% -$74K 0.09% 86
2021
Q3
$265K Hold
3,792
0.15% 87
2021
Q2
$257K Hold
3,792
0.15% 93
2021
Q1
$435K Buy
+3,792
New +$633K 0.31% 77

Other funds holding RVPH

EMC Capital Management's RVPH Position: Q2 2026 in Review

EMC Capital Management opened a new position in REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026: 6,696 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #52 among its holdings. This is a return to the name: EMC Capital Management previously reported a position in RVPH as recently as Q4 2025.

EMC Capital Management first reported a position in RVPH in Q1 2021 and has held it in 21 quarters since. The position peaked at $638K in Q3 2024. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • EMC Capital Management held 6,696 shares of REVIVA PHARMA HLDGS INC worth $3K as of Q2 2026.
  • REVIVA PHARMA HLDGS INC was a new EMC Capital Management position in Q2 2026.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of EMC Capital Management's portfolio in Q2 2026, its #52 holding.
  • EMC Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q1 2021 and has held it in 21 quarters since.
  • EMC Capital Management's REVIVA PHARMA HLDGS INC position peaked at $638K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on EMC Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.